Invesco’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.68B Buy
15,046,905
+2,321,024
+18% +$541M 0.36% 37
2025
Q4
$2.63B Sell
12,725,881
-888,354
-7% -$176M 0.25% 59
2025
Q3
$2.52B Sell
13,614,235
-402,720
-3% -$69M 0.4% 28
2025
Q2
$2.14B Sell
14,016,955
-4,457,751
-24% -$685M 0.36% 31
2025
Q1
$3.06B Sell
18,474,706
-651,373
-3% -$102M 0.58% 15
2024
Q4
$2.77B Buy
19,126,079
+1,171,975
+7% +$182M 0.51% 16
2024
Q3
$2.91B Buy
17,954,104
+1,294,785
+8% +$206M 0.56% 14
2024
Q2
$2.43B Buy
16,659,319
+2,391,806
+17% +$356M 0.52% 15
2024
Q1
$2.26B Buy
14,267,513
+985,345
+7% +$157M 0.48% 17
2023
Q4
$2.08B Buy
13,282,168
+794,844
+6% +$122M 0.5% 16
2023
Q3
$1.94B Sell
12,487,324
-1,257,315
-9% -$207M 0.52% 16
2023
Q2
$2.28B Sell
13,744,639
-157,019
-1% -$25.3M 0.6% 12
2023
Q1
$2.15B Buy
13,901,658
+1,282,831
+10% +$207M 0.6% 11
2022
Q4
$2.23B Sell
12,618,827
-791,524
-6% -$137M 0.65% 9
2022
Q3
$2.19B Buy
13,410,351
+33,649
+0.3% +$5.69M 0.71% 8
2022
Q2
$2.37B Buy
13,376,702
+710,155
+6% +$127M 0.72% 6
2022
Q1
$2.24B Buy
12,666,547
+140,537
+1% +$23.9M 0.57% 11
2021
Q4
$2.14B Buy
12,526,010
+1,012,136
+9% +$166M 0.52% 14
2021
Q3
$1.86B Buy
11,513,874
+1,178,956
+11% +$201M 0.47% 19
2021
Q2
$1.7B Buy
10,334,918
+24,481
+0.2% +$4.05M 0.42% 29
2021
Q1
$1.69B Buy
10,310,437
+114,496
+1% +$18.5M 0.45% 23
2020
Q4
$1.6B Sell
10,195,941
-1,351,576
-12% -$199M 0.47% 22
2020
Q3
$1.72B Sell
11,547,517
-871,882
-7% -$129M 0.58% 14
2020
Q2
$1.75B Sell
12,419,399
-421,041
-3% -$61.4M 0.62% 11
2020
Q1
$1.68B Buy
12,840,440
+554,116
+5% +$78.6M 0.71% 9
2019
Q4
$1.79B Buy
12,286,324
+333,614
+3% +$45.3M 0.56% 13
2019
Q3
$1.55B Buy
11,952,710
+85,299
+0.7% +$11.2M 0.4% 30
2019
Q2
$1.65B Buy
11,867,411
+506,221
+4% +$70.1M 0.43% 25
2019
Q1
$1.59B Sell
11,361,190
-18,971
-0.2% -$2.54M 0.54% 19
2018
Q4
$1.47B Sell
11,380,161
-219,488
-2% -$30.6M 0.56% 19
2018
Q3
$1.6B Buy
11,599,649
+5,155,023
+80% +$685M 0.5% 21
2018
Q2
$782M Buy
6,444,626
+820,285
+15% +$102M 0.26% 76
2018
Q1
$721M Sell
5,624,341
-940,724
-14% -$127M 0.27% 77
2017
Q4
$917M Sell
6,565,065
-90,473
-1% -$12.6M 0.33% 57
2017
Q3
$865M Sell
6,655,538
-103,939
-2% -$13.8M 0.32% 56
2017
Q2
$894M Buy
6,759,477
+27,451
+0.4% +$3.5M 0.28% 67
2017
Q1
$838M Sell
6,732,026
-1,173,415
-15% -$140M 0.28% 67
2016
Q4
$911M Sell
7,905,441
-227,083
-3% -$26.2M 0.31% 56
2016
Q3
$961M Sell
8,132,524
-652,761
-7% -$79.2M 0.33% 52
2016
Q2
$1.07B Buy
8,785,285
+9,826
+0.1% +$1.12M 0.39% 40
2016
Q1
$950M Buy
8,775,459
+572,974
+7% +$59.3M 0.39% 41
2015
Q4
$843M Sell
8,202,485
-276,329
-3% -$27.8M 0.34% 51
2015
Q3
$791M Sell
8,478,814
-1,209,598
-12% -$117M 0.34% 48
2015
Q2
$944M Sell
9,688,412
-562,311
-5% -$56.3M 0.37% 39
2015
Q1
$1.03B Buy
10,250,723
+1,858,478
+22% +$189M 0.4% 34
2014
Q4
$878M Buy
8,392,245
+1,137,692
+16% +$120M 0.34% 47
2014
Q3
$773M Sell
7,254,553
-936,219
-11% -$97.1M 0.31% 53
2014
Q2
$857M Sell
8,190,772
-1,148,434
-12% -$116M 0.34% 48
2014
Q1
$917M Sell
9,339,206
-1,406,634
-13% -$130M 0.37% 42
2013
Q4
$984M Sell
10,745,840
-1,592,616
-13% -$147M 0.39% 34
2013
Q3
$1.07B Sell
12,338,456
-2,515,920
-17% -$226M 0.46% 27
2013
Q2
$1.28B Buy
+14,854,376
New +$1.26B 0.59% 23

Other funds holding JNJ

Invesco's JNJ Position: Q1 2026 in Review

Invesco increased its Johnson & Johnson (JNJ) stake by 18% in Q1 2026, buying an estimated $541M and bringing the position to 15,046,905 shares worth $3.68B. The position accounts for 0.36% of the portfolio, ranked #37.

Invesco first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Invesco held 15,046,905 shares of Johnson & Johnson worth $3.68B as of Q1 2026.
  • Invesco bought 2,321,024 Johnson & Johnson shares in Q1 2026, an estimated $541M.
  • Johnson & Johnson made up 0.36% of Invesco's portfolio in Q1 2026, its #37 holding.
  • Invesco first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.